Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours

Maja de Jonge; SB Kaye; Jaap Verweij; C Brock; S Reade; M Mcurr; L van Doorn; Coleta Verheij; Walter Loos; CJ Brindley; P Mistry; M Cooper; I Judson

doi:10.1038/sj.bjc.6602178

Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours

Maja de Jonge, SB Kaye, Jaap Verweij, C Brock, S Reade, M Mcurr, L van Doorn, Coleta Verheij, Walter Loos, CJ Brindley, P Mistry, M Cooper, I Judson

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1459-1465
Number of pages	7
Journal	British Journal of Cancer
Volume	91
DOIs	https://doi.org/10.1038/sj.bjc.6602178
Publication status	Published - 2004

Research programs

EMC MM-03-86-08

Access to Document

10.1038/sj.bjc.6602178

http://hdl.handle.net/1765/66653

Cite this

de Jonge, M., Kaye, SB., Verweij, J., Brock, C., Reade, S., Mcurr, M., van Doorn, L., Verheij, C., Loos, W., Brindley, CJ., Mistry, P., Cooper, M., & Judson, I. (2004). Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours. British Journal of Cancer, 91, 1459-1465. https://doi.org/10.1038/sj.bjc.6602178

@article{509ce52090f948cfb538f4a7550e2342,

title = "Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours",

author = "{de Jonge}, Maja and SB Kaye and Jaap Verweij and C Brock and S Reade and M Mcurr and {van Doorn}, L and Coleta Verheij and Walter Loos and CJ Brindley and P Mistry and M Cooper and I Judson",

year = "2004",

doi = "10.1038/sj.bjc.6602178",

language = "Undefined/Unknown",

volume = "91",

pages = "1459--1465",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

}

de Jonge, M, Kaye, SB, Verweij, J, Brock, C, Reade, S, Mcurr, M, van Doorn, L, Verheij, C, Loos, W, Brindley, CJ, Mistry, P, Cooper, M & Judson, I 2004, 'Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours', British Journal of Cancer, vol. 91, pp. 1459-1465. https://doi.org/10.1038/sj.bjc.6602178

TY - JOUR

T1 - Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1-5 of a 3-weekly cycle in patients with advanced solid tumours

AU - de Jonge, Maja

AU - Kaye, SB

AU - Verweij, Jaap

AU - Brock, C

AU - Reade, S

AU - Mcurr, M

AU - van Doorn, L

AU - Verheij, Coleta

AU - Loos, Walter

AU - Brindley, CJ

AU - Mistry, P

AU - Cooper, M

AU - Judson, I

PY - 2004

Y1 - 2004

U2 - 10.1038/sj.bjc.6602178

DO - 10.1038/sj.bjc.6602178

M3 - Article

C2 - 15452551

SN - 0007-0920

VL - 91

SP - 1459

EP - 1465

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -